|Robert Gerard Pietrusko|
|Born||Robert Gerard Pietrusko|
|Education||BS, Bachelors of Pharmacy, Pharm.D|
Dr. Robert Gerard Pietrusko, Pharm.D is currently the Senior Vice President, Regulatory Affairs and Quality Assurance at Voyager Therapeutics, Inc.. According to Reuters, he is 69 years old. He completed his residency training at Thomas Jefferson University Hospital after receiving his BS and Bachelors in Pharmacy from Rutgers and his Pharm.D from Philadelphia College of Pharmacy and Science. He is considered one of "the most knowledgeable regulatory professionals in anti-infectives and antivirals today".
One such publication is Regulatory Aspects and Implications of Molecular Testing in the United States, which appears in the book Molecular Oncology of Breast Cancer.
His previous job was as Vice President, Global Regulatory Affairs and Quality and Executive Officer at ViroPharma Incorporated. While there, he was a major factor in the company's acquisition of Lev Pharmaceuticals, Inc. and its orphan drug Cinryze. His job before that was at Millennium Pharamcuticals, where he got Velcade approved. He also played a key role in the approvals of Havrix, Augmentin, and Infanrix. He has more than 30 NDAs and sNDAs to his name.
References[edit | edit source]
- "Stocks". Bloomberg.com.
- "Robert G. Pietrusko Joins ViroPharma as Vice President of Global Regulatory Affairs and Quality | Evaluate". www.evaluategroup.com. Retrieved 2017-09-21.
- Ross, Jeffrey Stuart; Hortobagyi, Gabriel N. (2005). Molecular Oncology of Breast Cancer. Jones & Bartlett Learning. ISBN 9780763748104.
- "Voyager Therapeutics Appoints Industry Veteran Robert G. Pietrusko, Pharm.D., to Senior Vice President of Regulatory Affairs". www.businesswire.com. Retrieved 2017-09-21.
|This article about a United States businessperson is a stub. You can help Wikipedia by expanding it.|
This article "Robert Pietrusko" is from Wikipedia. The list of its authors can be seen in its historical and/or its subpage Robert Pietrusko/edithistory. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.